Real-world evaluation of teplizumab in type 1 diabetes: Progression to insulin requirement. Mahesh S, Anson M, Malik RA, Cuthbertson DJ, et al. Diabetes Obes Metab 2025 Dec 22. doi: 10.1111/dom.70354.

Read + Share

Amedeo Smart

Independent Medical Education

Mahesh S, Anson M, Malik RA, Cuthbertson DJ, et al. Real-world evaluation of teplizumab in type 1 diabetes: Progression to insulin requirement. Diabetes Obes Metab 2025 Dec 22. doi: 10.1111/dom.70354.
PMID: 41424241